NO20085000L - Salter og krystallmodifikasjoner derav - Google Patents
Salter og krystallmodifikasjoner deravInfo
- Publication number
- NO20085000L NO20085000L NO20085000A NO20085000A NO20085000L NO 20085000 L NO20085000 L NO 20085000L NO 20085000 A NO20085000 A NO 20085000A NO 20085000 A NO20085000 A NO 20085000A NO 20085000 L NO20085000 L NO 20085000L
- Authority
- NO
- Norway
- Prior art keywords
- salts
- crystal modifications
- phenyl
- crystalline forms
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80283606P | 2006-05-23 | 2006-05-23 | |
| PCT/US2007/069327 WO2007140154A2 (en) | 2006-05-23 | 2007-05-21 | Salts and crystal modifications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20085000L true NO20085000L (no) | 2008-12-23 |
Family
ID=38704747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085000A NO20085000L (no) | 2006-05-23 | 2008-11-28 | Salter og krystallmodifikasjoner derav |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7977330B2 (pt) |
| EP (1) | EP2029556B1 (pt) |
| JP (2) | JP2009538330A (pt) |
| KR (1) | KR20090009898A (pt) |
| CN (1) | CN101448796B (pt) |
| AR (1) | AR061056A1 (pt) |
| AT (1) | ATE486858T1 (pt) |
| AU (1) | AU2007267671A1 (pt) |
| BR (1) | BRPI0712556A2 (pt) |
| CA (1) | CA2650514A1 (pt) |
| CL (1) | CL2007001454A1 (pt) |
| CR (1) | CR10431A (pt) |
| DE (1) | DE602007010286D1 (pt) |
| EC (1) | ECSP088900A (pt) |
| ES (1) | ES2355166T3 (pt) |
| GT (1) | GT200800253A (pt) |
| IL (1) | IL195008A0 (pt) |
| MA (1) | MA30482B1 (pt) |
| MX (1) | MX2008014836A (pt) |
| NO (1) | NO20085000L (pt) |
| PE (1) | PE20080261A1 (pt) |
| PL (1) | PL2029556T3 (pt) |
| PT (1) | PT2029556E (pt) |
| RU (1) | RU2008150627A (pt) |
| TN (1) | TNSN08477A1 (pt) |
| TW (1) | TW200815375A (pt) |
| WO (1) | WO2007140154A2 (pt) |
| ZA (1) | ZA200809096B (pt) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA012387B1 (ru) * | 2002-09-20 | 2009-10-30 | Эрроу Терапьютикс Лимитед | Производные бензодиазепина, содержащие их продукт и фармацевтическая композиция и их применение |
-
2007
- 2007-05-21 AR ARP070102191A patent/AR061056A1/es unknown
- 2007-05-21 PL PL07797606T patent/PL2029556T3/pl unknown
- 2007-05-21 AU AU2007267671A patent/AU2007267671A1/en not_active Abandoned
- 2007-05-21 KR KR1020087028592A patent/KR20090009898A/ko not_active Application Discontinuation
- 2007-05-21 JP JP2009512241A patent/JP2009538330A/ja active Pending
- 2007-05-21 CN CN2007800181255A patent/CN101448796B/zh not_active Expired - Fee Related
- 2007-05-21 US US12/298,203 patent/US7977330B2/en not_active Expired - Fee Related
- 2007-05-21 MX MX2008014836A patent/MX2008014836A/es not_active Application Discontinuation
- 2007-05-21 CA CA002650514A patent/CA2650514A1/en not_active Abandoned
- 2007-05-21 EP EP07797606A patent/EP2029556B1/en active Active
- 2007-05-21 BR BRPI0712556-9A patent/BRPI0712556A2/pt not_active Application Discontinuation
- 2007-05-21 RU RU2008150627/04A patent/RU2008150627A/ru not_active Application Discontinuation
- 2007-05-21 AT AT07797606T patent/ATE486858T1/de active
- 2007-05-21 PT PT07797606T patent/PT2029556E/pt unknown
- 2007-05-21 WO PCT/US2007/069327 patent/WO2007140154A2/en active Application Filing
- 2007-05-21 PE PE2007000619A patent/PE20080261A1/es not_active Application Discontinuation
- 2007-05-21 DE DE602007010286T patent/DE602007010286D1/de active Active
- 2007-05-21 ES ES07797606T patent/ES2355166T3/es active Active
- 2007-05-22 TW TW096118228A patent/TW200815375A/zh unknown
- 2007-05-22 CL CL200701454A patent/CL2007001454A1/es unknown
-
2008
- 2008-10-23 ZA ZA200809096A patent/ZA200809096B/xx unknown
- 2008-10-30 IL IL195008A patent/IL195008A0/en unknown
- 2008-11-10 CR CR10431A patent/CR10431A/es not_active Application Discontinuation
- 2008-11-21 GT GT200800253A patent/GT200800253A/es unknown
- 2008-11-21 EC EC2008008900A patent/ECSP088900A/es unknown
- 2008-11-21 TN TNP2008000477A patent/TNSN08477A1/en unknown
- 2008-11-26 MA MA31419A patent/MA30482B1/fr unknown
- 2008-11-28 NO NO20085000A patent/NO20085000L/no not_active Application Discontinuation
-
2013
- 2013-01-04 JP JP2013000196A patent/JP2013075910A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IL195008A0 (en) | 2009-08-03 |
| ATE486858T1 (de) | 2010-11-15 |
| CN101448796A (zh) | 2009-06-03 |
| US20090163478A1 (en) | 2009-06-25 |
| DE602007010286D1 (de) | 2010-12-16 |
| EP2029556A2 (en) | 2009-03-04 |
| AR061056A1 (es) | 2008-07-30 |
| TNSN08477A1 (en) | 2010-04-14 |
| MA30482B1 (fr) | 2009-06-01 |
| PE20080261A1 (es) | 2008-04-18 |
| CL2007001454A1 (es) | 2008-05-16 |
| EP2029556B1 (en) | 2010-11-03 |
| CN101448796B (zh) | 2012-09-26 |
| WO2007140154A3 (en) | 2008-03-20 |
| MX2008014836A (es) | 2008-12-01 |
| BRPI0712556A2 (pt) | 2013-07-02 |
| AU2007267671A1 (en) | 2007-12-06 |
| WO2007140154A2 (en) | 2007-12-06 |
| JP2009538330A (ja) | 2009-11-05 |
| KR20090009898A (ko) | 2009-01-23 |
| JP2013075910A (ja) | 2013-04-25 |
| ES2355166T3 (es) | 2011-03-23 |
| RU2008150627A (ru) | 2010-06-27 |
| GT200800253A (es) | 2009-04-29 |
| CA2650514A1 (en) | 2007-12-06 |
| TW200815375A (en) | 2008-04-01 |
| PL2029556T3 (pl) | 2011-04-29 |
| PT2029556E (pt) | 2011-01-31 |
| ZA200809096B (en) | 2009-11-25 |
| ECSP088900A (es) | 2008-12-30 |
| CR10431A (es) | 2009-01-07 |
| US7977330B2 (en) | 2011-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071073L (no) | Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
| EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
| NO20071549L (no) | Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler | |
| NO20076658L (no) | Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes | |
| NO20073875L (no) | Krystallformer av 1-klor-4-(B-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloksy)-benzyl]-benzen, metode for fremstilling samt anvendelse for fremstilling av medikamenter | |
| NO20023786L (no) | Heteroaromatiske karboksamidderivater og deres anvendelse som inhibitorer av enzymet IKK-2 | |
| NO20082482L (no) | Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer | |
| MY155230A (en) | Sulfoximine-substituted aniline pyrimidine derivatives as cdk inhibitors, their manufacture and use as medicine | |
| HUP0301513A2 (hu) | O-Aril-glükozid SGLT2 inhibitorok és eljárás elżállításukra | |
| NO20070432L (no) | Pyrimidinureaderivater som kinaseinhibitorer | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| NO20090064L (no) | Pyrasoler som glucokinase aktivatorer | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
| NO20083068L (no) | Optisk aktive karbamater, fremgangsmate for deres fremstilling og anvendelse derav som farmasoytiske mellomprodukter | |
| BRPI0918580B8 (pt) | polimorfo cristalino b da n-(2-aminofenil)-4-[n-(piridina3-il)metóxi-carbonilaminometil]-benzamida, composição e combinação contendo o mesmo, uso e seu processo de produção | |
| SE0400850D0 (sv) | Novel Compounds | |
| ATE438617T1 (de) | Substituierte cyclohexyl-1,4-diamin-derivate | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer | |
| WO2007024600A3 (en) | Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof | |
| BR0312593A (pt) | Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação | |
| ATE471312T1 (de) | Diaryltriazolmethylamin-derivate sowie ihre herstellung und therapeutische verwendung | |
| UA84455C2 (en) | Crystalline pyrazole derivatives | |
| NO20085000L (no) | Salter og krystallmodifikasjoner derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |